JFS Wealth Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Hold
63
﹤0.01% 927
2026
Q1
$14.1K Sell
63
-22
-26% -$5.48K ﹤0.01% 832
2025
Q4
$20.5K Buy
85
+35
+70% +$8.95K ﹤0.01% 739
2025
Q3
$13.7K Hold
50
﹤0.01% 800
2025
Q2
$12.9K Buy
50
+6
+14% +$1.43K ﹤0.01% 786
2025
Q1
$9.85K Buy
44
+1
+2% +$233 ﹤0.01% 887
2024
Q4
$9.83K Buy
43
+1
+2% +$241 ﹤0.01% 857
2024
Q3
$10.3K Buy
42
+2
+5% +$447 ﹤0.01% 843
2024
Q2
$7.66K Hold
40
﹤0.01% 880
2024
Q1
$7.92K Sell
40
-5
-11% -$916 ﹤0.01% 897
2023
Q4
$7.74K Buy
45
+43
+2,150% +$6.61K ﹤0.01% 874
2023
Q3
$296 Sell
2
-36
-95% -$6.51K ﹤0.01% 1817
2023
Q2
$8.3K Sell
38
-7
-16% -$1.56K ﹤0.01% 792
2023
Q1
$9.86K Buy
45
+3
+7% +$651 ﹤0.01% 727
2022
Q4
$8.74K Sell
42
-18
-30% -$3.96K ﹤0.01% 761
2022
Q3
$13K Buy
60
+36
+150% +$8.19K ﹤0.01% 661
2022
Q2
$5K Sell
24
-22
-48% -$4.68K ﹤0.01% 1008
2022
Q1
$11K Buy
46
+29
+171% +$7.01K ﹤0.01% 770
2021
Q4
$4K Buy
+17
New +$4.41K ﹤0.01% 877
2020
Q3
Sell
-101
Closed -$19K 595
2020
Q2
$19K Buy
+101
New +$16.5K ﹤0.01% 309
2019
Q2
Sell
-34
Closed -$4K 479
2019
Q1
$4K Buy
+34
New +$3.51K ﹤0.01% 405

Other funds holding RMD

JFS Wealth Advisors's RMD Position: Q2 2026 in Review

JFS Wealth Advisors held its ResMed (RMD) position steady in Q2 2026 at 63 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #927.

JFS Wealth Advisors first reported a position in RMD in Q1 2019 and has held it in 21 quarters since. The position peaked at $20.5K in Q4 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • JFS Wealth Advisors held 63 shares of ResMed worth $12.3K as of Q2 2026.
  • JFS Wealth Advisors left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #927 holding.
  • JFS Wealth Advisors first reported a position in ResMed in Q1 2019 and has held it in 21 quarters since.
  • JFS Wealth Advisors's ResMed position peaked at $20.5K in Q4 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.